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Research
Extreme temperatures have been associated 
with hospitalization and death among sus-
ceptible populations (Basu et al. 2008; Bell 
et al. 2008; Koken et al. 2003; Zanobetti and 
Schwartz 2008) and individuals with conges-
tive heart failure may be particularly vulner-
able (Cui et al. 2005). Cold temperatures 
have been linked to hospital admissions for 
heart failure and incidence of cardiovascular 
events (Martinez-Selles et al. 2004; Stewart 
et al. 2002), but increases in morbidity and 
mortality have been observed during peri-
ods of hot weather as well (Aronow and 
Ahn 2004). It is possible that the biological 
mechanisms underlying cardiovascular health 
effects may vary across the range of ambient 
outdoor temperatures observed throughout 
the year. However, only a few studies have 
examined these associations in heart failure 
patients (Barclay et al. 2009; Goldberg et al. 
2009). Moreover, it is not clear if short-term 
changes in weather patterns can be linked to 
preclinical changes in heart failure status.
Levels of biomarkers that reflect myo-
cardial damage and inflammation are elevated 
in heart failure patients and typically rise fur-
ther during episodes of acute cardiac decom-
pensation (Fonarow 2008). B-type natriuretic 
peptide (BNP), a neurohormone produced 
principally by the ventricles of the heart in 
response to increasing wall stress, has been 
shown to be a predictor of sudden death 
among individuals with chronic heart failure 
(Berger et al. 2002) and has been associated 
with increased risk of readmission (Logeart 
et al. 2004) among individuals hospitalized 
for decompensation.
Elevated levels of biomarkers of systemic 
inflammation, immune function, and ven-
tricular remodeling, such as C-reactive pro-
tein (CRP), tumor necrosis factor (TNF), and 
endothelin-1, also have been associated with 
morbidity and mortality among heart failure 
patients (Alonso-Martinez et al. 2002; Anand 
et al. 2005; Dunlay et al. 2008; Teerlink 
2005). The evaluation of a panel of biomark-
ers may provide insight into underlying disease 
pathology and targeted therapeutic responses 
(Braunwald 2008). For this analysis, we inves-
tigated the association between ambient tem-
perature and four biomarkers of heart failure 
in a population of individuals with stable sys-
tolic heart failure using a repeated-measures 
approach. We hypothesized that higher ambi-
ent and apparent temperature would be asso-
ciated with elevated levels of these measures, 
which are associated with heart failure severity 
and prognosis.
Materials and Methods
We analyzed data from a completed clinical 
trial that randomized 100 patients with stable 
heart failure and impaired systolic function to 
receive either 12 weeks of 1-hour group tai chi 
classes or time-matched heart failure educa-
tion (the control) in addition to usual care. 
Methodological details and the primary trial 
results have been published elsewhere (Yeh et al. 
2011). Patients who chose to participate in the 
study provided written informed consent; this 
study was approved by the institutional review 
boards of all   participating institutions.
Participants were recruited from ambula-
tory clinics (primary care, general cardiol-
ogy, and specialty heart failure practices) at 
three academic medical centers in and around 
Boston, Massachusetts. The inclusion criteria 
were physician diagnosis of chronic systolic 
heart failure, left ventricular ejection frac-
tion ≤ 40% in the past 2 years; stable med-
ical regimen that was defined as no major 
changes in medication in the past 3 months; 
and a designation of class I, II, or III for heart 
failure as defined by the New York Heart 
Association (Criteria Committee of the New 
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Ba c k g r o u n d: Extreme temperatures have been associated with hospitalization and death among 
individuals with heart failure, but few studies have explored the underlying mechanisms. 
oBjectives: We hypothesized that outdoor temperature in the Boston, Massachusetts, area 
(1‑ to 4‑day moving averages) would be associated with higher levels of biomarkers of inflammation 
and myocyte injury in a repeated‑measures study of individuals with stable heart failure.
Me t h o d s : We analyzed data from a completed clinical trial that randomized 100 patients to 
12 weeks of tai chi classes or to time‑matched education control. B‑type natriuretic peptide (BNP), 
C‑reactive protein (CRP), and tumor necrosis factor (TNF) were measured at baseline, 6 weeks, and 
12 weeks. Endothelin‑1 was measured at baseline and 12 weeks. We used fixed effects models to 
evaluate associations with measures of temperature that were adjusted for time‑varying covariates.
re s u l t s: Higher apparent temperature was associated with higher levels of BNP beginning with 
2‑day moving averages and reached statistical significance for 3‑ and 4‑day moving averages. CRP 
results followed a similar pattern but were delayed by 1 day. A 5°C change in 3‑ and 4‑day moving 
averages of apparent temperature was associated with 11.3% [95% confidence interval (CI): 1.1, 
22.5; p = 0.03) and 11.4% (95% CI: 1.2, 22.5; p = 0.03) higher BNP. A 5°C change in the 4‑day 
moving average of apparent temperature was associated with 21.6% (95% CI: 2.5, 44.2; p = 0.03) 
higher CRP. No clear associations with TNF or endothelin‑1 were observed.
co n c l u s i o n s: Among patients undergoing treatment for heart failure, we observed positive asso‑
ciations between temperature and both BNP and CRP—predictors of heart failure prognosis and 
  severity.
key w o r d s : biomarkers, climate variability, heart failure, outdoor air, susceptibility. Environ Health 
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York Heart Association 1994). The exclusion 
criteria were unstable angina or myocardial 
infarction in the past 3 months, major cardiac 
surgery within the past 3 months, history of 
cardiac arrest in the past 6 months, history 
of cardiac resynchronization therapy in the 
past 3 months, unstable serious ventricular 
arrhythmias, unstable structural valvular dis-
ease, current participation in a conventional 
cardiac rehabilitation program, diagnosis of 
peripartum cardiomyopathy within the pre-
ceding 6 months, inability to perform a bicy-
cle stress test, lower extremity amputation or 
other inability to ambulate because of condi-
tions other than heart failure, severe cognitive 
dysfunction (Mini-Mental State Examination 
score ≤ 24; Folstein et al. 1975), inability to 
speak English, or regular practice of tai chi.
Biomarkers. Blood samples were drawn 
from participants in a nonfasting state at the 
time of the study visit. BNP was analyzed in 
whole blood collected in EDTA (ethylene-
diamine-tetraacetic acid) using a commercially 
available point-of-service meter (fluorescence 
immunoassay; Biosite Triage BNP Test; 
Biosite Diagnostics, San Diego, CA). Serum 
samples were also analyzed for CRP using DPC 
(Diagnostic Products Corporation) Siemens 
Immulite high sensitivity hsCRP immunoassay 
(Siemens AG, Munich, Germany), for endothe-
lin-1 using DPC Siemens chemi  luminescent 
QuantiGLO ELISA (Siemens AG), and for 
TNF using Quantikine TNF-α immuno-
assay (R&D Systems, Inc., Minneapolis, 
MN). Blood samples were drawn at baseline, 
at 6 weeks, and at 12 weeks. The percentages 
of the coefficient of variation (CV%) of the 
intra  assay and inter  assay for these kits were 
8.8–11.6% and 9.9–12.2%, respectively, for 
BNP; 4.2–6.4% and 4.8–10.0%, respectively, 
for CRP; 3.1% and 6.7%, respectively, for 
endothelin-1; and 5.3% and 8.4%, respec-
tively, for TNF.
Pollution and weather data. Ambient 
temperature, relative humidity, dew point 
temperature, and barometric pressure were 
obtained from the National Weather Service 
(National Climatic Data Center 2011) daily 
summaries of meteorological data measured 
at Logan International Airport (Boston, MA). 
Apparent temperature is a metric used to 
describe how people perceive the combina-
tion of temperature and humidity (Steadman 
1984). The values for apparent temperature 
are based on the measures of ambient and 
dew point temperature and were calculated 
using the following formula:
Apparent temperature =  
–2.653 + [0.994 × 24-hr mean air 
temperature (°C)] + [0.0153 × 24-hr 
mean dew point temperature (°C)2]  [1]
We obtained hourly measures of ambient 
fine particulate matter (PM ≤ 2.5 µm in aero-
dynamic diameter; PM2.5) from the Harvard 
Countway Library SuperSite (Boston, MA) 
and ozone from the averages of five U.S. 
Environmental Protection Agency monitors 
located within the Boston Area.
Statistical methods. The biomarker data 
(CRP, BNP, endothelin-1, and TNF) were 
examined using summary statistics and distri-
butional plots to identify outliers and assess 
normality. Log-transformation of biomarkers 
was performed for all analyses. Outliers were 
defined as values falling outside 1.5 times the 
interquartile range of the data. There were 
two outliers identified for endothelin-1 and 
one outlier for TNF. Analyses were conducted 
including all observations and also excluding 
outlier observations.
Separate models were constructed for 
one to four day moving averages of ambi-
ent and apparent temperature for each bio-
marker using fixed-effects regression in 
R (version 2.9; R Foundation for Statistical 
Computing, Vienna, Austria) with the plm 
package for repeated-measures data. Unlike 
mixed-effects models commonly used in 
unbalanced repeated-measures analyses, which 
borrow information at the population level 
to account for within- and between-person 
variability, fixed-effects regression controls 
for all between-person differences by estimat-
ing subject-specific intercepts, thus isolating 
the within-person estimates of association. 
Although this approach is more commonly 
used in the field of econo  metrics (Hausman 
1978; Hausman and Taylor 1981), it also has 
previously been used in air pollution studies 
(Gold et al. 2000; Rückerl et al. 2006). In 
this model, each participant forms their own 
stratum analogous to a conditional logistic 
regression framework for binary outcomes in 
a case-crossover study. The model provides 
estimates for the time-varying covariates only, 
because time invariant covariates do not 
change within person. The model takes the 
general form
 y it = Xitβ + αi + eit,  [2]
where yit is the outcome y at time t for the 
ith subject, Xit is a matrix of time-varying 
predictors, αi is a random intercept for each 
subject, and eit is the error term. In the pri-
mary analyses, ambient and apparent tem-
perature were modeled as continuous linear 
functions. All models were adjusted for time 
and seasonality using a harmonic function 
[sine (2π × day of year/365.25) and cosine 
(2π × day of year/365.25)], day of week, and 
body weight at each visit as a marker of hydra-
tion status. Models of ambient temperature 
were additionally adjusted for corresponding 
moving-average values of relative humidity 
and barometric pressure. Models of appar-
ent temperature were adjusted for barometric 
pressure only because the formula for apparent 
temperature accounts for the dew point tem-
perature. We also tested for effect modifica-
tion by diabetes status, sex, and randomization 
to the tai chi treatment arm of the study using 
cross-product terms and examining statistical 
significance at p < 0.05.
In a sensitivity analysis, we adjusted for 
corresponding moving averages of PM2.5 and 
ozone in separate models. We also included 
both linear and quadratic terms for relative 
humidity and pressure. To further explore 
potential nonlinear relationships, we used the 
mgcv package for generalized additive mod-
els (version 1.6; R Foundation for Statistical 
Computing) to fit penalized splines. We 
hypothesized that changes in temperature 
could be associated with different physiologic 
Table 1. Patient characteristicsa at initial visit.
Characteristic
Mean ± SD or  
no. of participants
Age (years) 67 ± 12.0
Sex (female) 36
Nonwhite ethnicity 14
Income > $50,000 42
Refused to answer 14
Smokingb 10
Alcohol useb 48
Left ventricular ejection fraction 29.0 ± 7.6















  receptor blockers
85
an = 100 participants. bCurrent use (yes).
Table 2. Pollution and meteorology for study visit days (n = 285).
Pollution and weather Mean ± SD Median Minimum Maximum
Ambient temperature (°C) 13 ± 9 14 –11 27
Apparent temperature (°C) 12 ± 10 13 –7 30
Relative humidity (%) 66 ± 15 66 30 99
Barometric pressure (mmHg) 761 ± 7 760 740 776
Ozone (ppb) 24 ± 10 22 30 66
PM2.5 (µg/m3) 8.7 ± 5.3 7.2 0.2 29.9Temperature and biomarkers of heart failure
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responses in summer and winter. Therefore, 
we performed sensitivity analyses by subsetting 
to season when visits began, defined as warm 
(March through August) or cool (September 
through February) seasons and also tested for 
interactions using a cross-product term and 
examining statistical significance of this term 
at p < 0.05. In a sensitivity analysis, we also fit 
linear-mixed models with random effects for 
all four biomarkers using the plm package. No 
material difference was observed, so we present 
results for fixed effects only. All results are pre-
sented as a percent change for a 5°C increase 
in either ambient or apparent temperature 
measure with 95% confidence interval (CI). 
This increment was chosen to be representa-
tive of day-to-day variability in temperature in 
the Boston area.
Results
In Table 1, we show the characteristics of the 
study population. Participants were predomi-
nantly male (64%) and white (86%). The age 
at baseline ranged from 34 to 96 years (mean 
± SD of 67.4 ± 12). Table 2 summarizes the 
daily meteorological data during the study 
period. Ambient temperature ranged from –11 
to 27°C throughout the study period (mean ± 
SD of 12.5 ± 9.0) and was highly correlated 
with apparent temperature (Spearman correla-
tion > 0.9). The median of the within-person 
range in ambient temperature across study 
visits was 13°C. The largest within-person 
range in both ambient and apparent tem-
perature was observed for participants who 
began the study in mid-  September, when 
Boston weather patterns may still be quite 
like summer, and who completed the study 
in mid-December. Distributions of the bio-
markers and their correlations are described 
in Table 3 by visit. All 100 participants in the 
study provided baseline blood samples for the 
BNP assessment. Three samples were available 
for 89 of these participants. There were four 
participants who provided only one sample. 
Endothelin-1 measures typically occurred at 
visits 1 and 3, but 8 samples were analyzed 
at visit 2 when visit 1 or visit 3 data were 
unavailable. Figure 1 shows the results from 
the fully adjusted models of apparent temper-
ature. Higher apparent temperature was asso-
ciated with higher levels of BNP beginning 
with 2-day moving averages and reached sta-
tistical significance for 3- and 4-day moving 
averages. Specifically, we observed that a 5°C 
change in 3- and 4-day moving averages of 
apparent temperature were positively associ-
ated with an 11.3% higher (95% CI: 1.1, 
22.5; p = 0.03) and an 11.4% higher (95% 
CI: 1.2, 22.5; p = 0.03) BNP, respectively. 
CRP results followed a similar pattern, but 
were delayed by 1 day; CRP levels were sig-
nificantly higher after 4-day moving averages, 
and a 5°C change in apparent temperature 
was associated with 21.6% higher CRP (95% 
CI: 2.5, 44.2; p = 0.03). No clear association 
was observed between apparent temperature 
and endothelin-1 or TNF. Inclusion of outli-
ers did not materially change these findings. 
Similar results were observed for ambient tem-
perature for all outcomes (data not shown). 
We found no evidence of effect modification 
by season, diabetes status, sex, or randomiza-
tion to tai chi treatment using cross-product 
terms and a p-value of 0.05 as the criterion 
for significance (data not shown).
In the analyses examining the exposure– 
response relationships between temperature 
and biomarkers, we did not observe substan-
tial deviations from linearity [see Supplemental 
Material, Figure S1 (http://dx.doi.org/10.1289/
ehp.1104380)]. We observed no clear evidence 
of nonlinear relation  ships, and none of the 
spline terms were statistically significant (all 
p > 0.05). Adjustment for PM2.5 or ozone as 
potential confounders did not substantially alter 
our results (data not shown).
Discussion
In this analysis of the association between 
temperature measures and biomarkers related 
to inflammation and cardiovascular function 
in a population of heart failure patients, we 
observed higher levels of BNP beginning with 
2-day moving averages. These results reached 
statistical significance for moving averages of 
3 and 4 days. CRP results followed a simi-
lar pattern but were delayed by 1 day. These 
two biomarkers reflect interrelated mecha-
nisms known to be associated with heart fail-
ure prognosis and symptom severity. CRP is 
a an indicator of systemic inflammation and 
is associated with risk of heart failure decom-
pensation (Sato et al. 1999), whereas BNP 
is more specifically a marker of increasing 
hemodynamic load used in diagnosis and risk 
stratification among patients with congestive 
heart failure (Koglin et al. 2001). Predischarge 
BNP is a strong independent predictor of 
postdischarge outcome (Logeart et al. 2004) 
and long-term prognosis (Latini et al. 2002). 
To our knowledge, this is the first evidence 
that within-person BNP levels may be elevated 
during episodes of increased temperature. The 
results reported in this study are scaled to a 
5°C change. Because we were examining asso-
ciations across a season, the within-person dif-
ferences in temperature could be quite large. 
We selected a 5°C change to represent the 
typical day-to-day variability in temperature 
within the Boston area. This is well within the 
range of data that we observe and represents a 
relatively small within-person change.
The levels of the inflammatory markers we 
observed in our study population of individuals 
with heart failure were elevated, as expected 
in a population of heart failure patients. For 
example, a BNP level of 100 pg/mL is typically 
used as a clinical cutoff for diagnosis of heart 
failure and decompensation, and the prognostic 
value of elevated plasma BNP in symptomatic 
systolic heart failure has been consistently 
reliable in various clinical settings (Cheng 
et al. 2001). For context, the magnitude of 
the association between temperature and 
Table 3. Description of inflammatory markers at each visit.














BNP (pg/mL) 100 112.48 103.5 (44.3, 284.5) 92 97.71 90.4 (40.9, 238) 93 106.54 110 (46.7, 223)
CRP (mg/L) 81 2.81 3.1 (0.94, 6.89) 76 2.17 1.84 (0.92, 5.60) 73 2.58 1.88 (0.93, 7.86)
Endothelin-1 (pg/mL)a 90 2.31 2.32 (1.80, 2.90) 8b 1.813 1.77 (1.56, 2.03) 90 2.42 2.39 (1.94, 2.92)
TNF (pg/mL)a 95 1.70 1.65 (1.11, 2.07) 89 1.65 1.59 (1.14, 2.19) 86 1.62 1.47 (1.19, 2.02)
aOutlier observations are included. bEndothelin-1 measures typically occurred at visits 1 and 3, but 8 samples were analyzed at visit 2 when visit 1 or visit 3 data were unavailable.
Figure 1. The percent change and 95% CIs for BNP, 
CRP, endothelin-1, and TNF for 1- to 4-day moving 
averages. Estimated changes in biomarker levels 
associated with a 5°C change in moving average 
temperature over the previous 1–4 days. All models 
are adjusted for day of week, sine, and cosine of 
day of year, body weight, and atmospheric pres-
sure. BNP models include 100 participants with 285 
measures; CRP models include 81 participants with 
230 measures; endothelin-1 models include 93 par-
ticipants with 186 measures (two outlier observa-
tions were not included); and TNF models include 
99 participants with 269 observations (one outlier 
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BNP observed in this study indicates that 
10°C higher temperature is associated with 
approximately one-third of the impact of a 
transient increase in sodium load from 1,610 
mg/day to 5,750 mg/day for subjects with 
established heart failure, a stimulus that may 
trigger decompensation in some patients 
(Damgaard et al. 2007).
Most prior studies of environmental deter-
minants in heart failure patients have focused 
on hospitalizations and mortality rather than 
symptoms and preclinical changes. Studies 
that have examined seasonal trends in hospital 
admissions and mortality for heart failure have 
typically observed a winter peak (Barnett et al. 
2008; Boulay et al. 1999; Stewart et al. 2002). 
In a recent study, Gotsman et al. (2010) 
examined the association between tempera-
ture and prognosis in heart failure patients. 
They showed greater rates of hospitalization 
in the winter time but also found that warmer 
weather and admission during summer months 
were positively associated with symptom sever-
ity, prognosis, and reduced survival. To our 
knowledge, there is only one panel study that 
has directly examined health effects of tem-
perature in heart failure patients. In this study, 
which was conducted in Montreal, Quebec, 
Goldberg et al. (2008) found an inverse asso-
ciation between oxygen saturation and maxi-
mum air temperature and relative humidity. 
They also found that maximum ambient air 
temperature, higher relative humidity, and 
ozone on the concurrent day predicted poorer 
self-reported general health (Goldberg et al. 
2009). In our analyses of associations between 
temperature and biomarkers of heart failure, 
we observed positive associations with higher 
air temperature moving averages but not with 
relative humidity or ozone. This result may 
be due to the differences in the outcomes and 
also the differences in time windows assessed, 
Goldberg only tested lags of 0–2 days (3-day 
average). Our findings suggest an association 
with BNP after only two days, but it is possi-
ble that longer integrated averages of tempera-
ture over several days, which reflect a period of 
prolonged elevated temperature, are necessary 
to observe upregulation of CRP.
We are not aware of any previous studies 
investigating the effects of temperature with 
BNP or with CRP in heart failure patients. 
However, prior studies have reported the 
associations between temperature and CRP 
in other populations, and the results have 
been mixed (Halonen et al. 2010; Hampel 
et al. 2010; Schneider et al. 2008). Halonen 
et al. (2010) estimated temperature effects in 
a relatively healthy cohort of men and also 
observed inverse associations between tem-
perature and CRP for lags of 0–1 day and for 
moving averages of up to 4 weeks. Schneider 
et al. (2008) measured CRP within a popula-
tion of myocardial infarction survivors and 
observed inverse associations with tempera-
ture for averages and lags < 1 week. However, 
a more recent study by Hampel et al. (2010) 
contrasted patients with coronary heart dis-
ease and pulmonary disease in their responses 
to temperature and found no association with 
CRP among patients with pulmonary disease 
and lower CRP associated with lower tem-
perature (corresponding to a positive asso-
ciation) for almost all lags among coronary 
heart disease patients. As has been suggested 
by these authors, differences in populations 
and their comorbidities and patterns of medi-
cation use may explain discrepant findings 
(Hampel et al. 2010).
We did not observe any evidence of asso-
ciations with either TNF or endothelin-1 and 
temperature. Endothelin-1 is released from 
endothelial cells and has strong vasoconstric-
tive properties. Higher levels of endothelin-1 
have been associated with heart failure sever-
ity and higher mortality rates (Bolger et al. 
2002; Wei et al. 1994; Yang et al. 2005). In 
this analysis of only two measures per sub-
ject, we may not have had sufficient power 
to detect within-person changes. We note 
that 90% of endothelin-1 is synthesized in 
the endothelium and acts on the vascular 
smooth muscle locally (Levin 1995). TNF 
is a cytokine associated with inflammatory 
properties that also has been associated with 
severity and risk stratification of heart failure 
in a number of studies (Levine et al. 1990; 
Sharma et al. 2000). Our results are consis-
tent with those of Halonen et al. (2010) who 
did not observe any significant association 
between temperature and TNF among older 
men also residing within the same region as 
our study participants.
Although we addressed the shape of the 
exposure–response relationship using penal-
ized splines in additional analyses, we did 
not observe any statistically significant devi-
ation from linearity. The only models with 
estimated degrees of freedom (df) > 1 were 
for endothelin-1, and these associations were 
nonsignificant (the estimated 1-day moving 
average df was 2.3; p = 0.4). In our analyses, 
neither PM2.5 nor ozone confounded the asso-
ciation between temperature and biomarkers 
and were not significantly associated with bio-
marker levels. We previously observed no con-
sistent association between BNP and PM2.5 in 
a similar population of heart failure patients 
in the Boston area (Wellenius et al. 2007). 
Similar results were also observed in Aberdeen, 
Scotland, where there was no change in the 
number of hematological parameters mea-
sured in response to air pollution exposures in 
a panel of 132 heart failure patients (Barclay 
et al. 2009). However, our findings differ 
from other studies that have shown that PM2.5 
is associated with changes in inflammatory 
biomarker levels in older aging populations 
(Dubowsky et al. 2006; Wilker et al. 2011), 
individuals with diabetes (O’Neill et al. 2007),   
and persons with coronary artery disease 
(Delfino et al. 2008). Heart failure patients 
may spend less time outside and have differ-
ent time-activity and exposure patterns from 
healthy individuals and from those with other 
chronic conditions (Oka et al. 1993; van den 
Berg-Emons et al. 2001). These differences 
could also potentially explain our findings 
of no substantial deviations from linearity in 
the exposure–response relationship, if these 
patients with chronic heart failure are more 
vulnerable to extreme heat and spend little 
time outdoors during periods of extreme cold.
Potential limitations of this study include 
a limited number of repeated measures on 
study participants. This study specifically 
enrolled patients with heart failure and systolic 
dysfunction. Therefore, the results may not be 
generalizable to patients with heart failure and 
preserved systolic function. Additionally, the 
purpose of the original study was to examine 
effects of tai chi. This intervention was found 
to be associated with improved quality-of-
life measures, but randomization to tai chi 
was not associated with statistically significant 
changes in the levels of these biomarkers (Yeh 
et al. 2011), and we did not observe any evi-
dence of effect modification by tai chi ran-
domization status in our analysis. We are also 
limited in our ability to assess spatial hetero-
geneity of the temperature metric, because we 
used only one stationary site for our analyses. 
Most (88%) participants in our study popula-
tion lived within 40 km of Boston and our 
central site monitor; therefore, we expected to 
have limited misclassification for our within-
person analyses. However, this study did not 
collect information on air-conditioner usage 
and availability, which also may be a source 
of variability in heat-related physiologic 
responses (Curriero et al. 2002; O’Neill et al. 
2005; Ostro et al. 2010).
As mentioned above, time-activity patterns 
(Oka et al. 1993; van den Berg-Emons et al. 
2001) could potentially confound or modify 
associations between temperature and these 
biomarkers, but we did not have sufficient 
data to address this topic. It is also possible 
that hemoconcentration could, in part, explain 
the associations between temperature and 
biomarkers, in situations where participants 
become more dehydrated in warmer weather. 
Data on blood urea nitrogen or hematocrit 
were not available in this study, but we did 
include body weight at each visit as a marker 
of hydration status in heart failure patients 
and found that the changes in the estimated 
association between temperature and the bio-
markers were negligible (< 5%).
In this study of 100 patients with heart 
failure and systolic dysfunction, we observed 
significantly higher BNP and CRP, which Temperature and biomarkers of heart failure
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are biomarkers related to heart failure symp-
toms and prognosis, with 3- to 4-day moving 
averages of apparent temperature. These find-
ings suggest that changes in temperature and 
meteorology may alter underlying physio-
logic responses in this vulnerable population. 
Because of their compromised hemo  dynamic 
response, individuals with heart failure may 
have increased stress in the ventricles, as 
reflected by a rapid increase in circulating BNP 
levels, which may be accompanied or perhaps 
followed by elevation in systemic inflamma-
tory responses, as indicated by CRP. Given 
the large public health burden of heart failure, 
further work is needed to examine the role 
of ambient temperature in influencing pre-
clinical changes that occur before an episode   
of acute heart failure decompensation.
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